Coronary Artery Calcium Score and Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia Patients Undergoing Standard Lipid Lowering Therapy

被引：0
|
作者：
Miname, Marcio [1 ]
Bittencourt, Marcio S. [2 ]
Moraes, Sergio R. [1 ]
Alves, Romulo, I [1 ]
Silva, Pamela R. [1 ]
Jannes, Cinthia E. [1 ]
Pereira, Alexandre C. [1 ]
Nasir, Khurram [3 ]
Santos, Raul D. [1 ]
机构：
[1] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil
[2] FICSAE, Med, Sao Paulo, Brazil
[3] Yale Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Calcification; Lipids;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11937
引用
收藏
页数：2
相关论文
共 50 条
  • [21] High Cardiovascular Disease Risk and Low Lipid-Lowering Treatment in Heterozygous Familial Hypercholesterolemia Patients: A French Nationwide Registry
    Ferrieres, J.
    Farnier, M.
    Bruckert, E.
    Vimont, A.
    Beliard, S.
    VALUE IN HEALTH, 2022, 25 (12) : S198 - S198
  • [22] Defining Patients at Extremely High Risk for Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia
    Sugisawa, Takako
    Okamura, Tomonori
    Makino, Hisashi
    Watanabe, Makoto
    Kishimoto, Ichiro
    Miyamoto, Yoshihiro
    Iwamoto, Noriyuki
    Yamamoto, Akira
    Yokoyama, Shinji
    Harada-Shiba, Mariko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (04) : 369 - 375
  • [23] Montreal score and coronary artery calcification in the prediction of cardiovascular event in patients with familial hypercholesterolemia
    Miname, M.
    Bittencourt, M. S. B.
    Jannes, C. E. J.
    Pereira, A. C. P.
    Krieger, J. E. K.
    Santos, R. D. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3226 - 3226
  • [24] Molecular Defects Are Not Associated With Occurrence of Cardiovascular Events in Older Individuals With Familial Hypercholesterolemia on Lipid Lowering Therapy
    Coutinho, Elaine
    Miname, Marcio H.
    Rocha, Viviane Z.
    Bittencourt, Marcio S.
    Jannes, CInthia
    Pereira, Alexandre
    Krieger, Jose
    Santos, Raul D.
    CIRCULATION, 2021, 144
  • [25] The effect of LP(a) in patients with heterozygous familial hypercholesterolemia on coronary plaque burden and calcium score determined by CT
    Bos, S.
    Ten Kate, G. -J. R.
    Sijbrands, E. J. G.
    Mulder, M. T.
    Van Lennep, J. E. Roeters
    EUROPEAN HEART JOURNAL, 2013, 34 : 963 - 963
  • [26] Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia
    Hopkins, PN
    Stephenson, S
    Wu, LL
    Riley, WA
    Xin, YP
    Hunt, SC
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05): : 547 - 553
  • [27] Coronary artery calcification is an independent predictor of cardiovascular events in familial hypercholesterolemia
    Miname, M. H.
    Silva, P. R. S.
    Alves, R. L. M.
    Moraes, S. R.
    Bittencourt, M. S.
    Rocha, V. Z.
    Marte, A. P.
    Salgado, W.
    Jannes, C. E.
    Pereira, A. C.
    Santos, R. D.
    EUROPEAN HEART JOURNAL, 2017, 38 : 311 - 312
  • [28] Coronary Artery Calcium Score in Patients With Heterozygous Familial Hypercholesterolemia is Proportional to Lifetime LDL Burden After up to 28 Years of Treatment
    Duell, P. Barton
    CIRCULATION, 2013, 128 (22)
  • [29] Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events
    Sampietro, Tiziana
    Sbrana, Francesco
    Bigazzi, Federico
    Dal Pino, Beatrice
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2022, 41 (09) : 805 - 807
  • [30] Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia
    Paquette, Martine
    Cariou, Bertrand
    Bernard, Sophie
    Hegele, Robert A.
    Gallo, Antonio
    Genest, Jacques
    Trinder, Mark
    Brunham, Liam R.
    Beliard, Sophie
    Baass, Alexis
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (02) : 505 - 512
12345